DUBLIN, September 21, 2017 /PRNewswire/ --
The "Global Autoimmune Disease Treatment Market - By Disease Type, Diagonostics, Products, Region - Market Size, Demand Forecasts, Industry Trends and Updates (2016-2022)" report has been added to Research and Markets' offering.
Global autoimmune diseases treatment market is estimated to grow at a CAGR of 3.80% for the forecasted period, and its market value is expected to reach $45.54 billion by 2022 from $36.41 billion in 2016
Autoimmune diseases occur when the immune system of an individual's body treats healthy cells of his/her very own body as foreign cells and attacks them. These diseases causes variations in organ functioning, abnormal growth of organs and destruction of healthy body tissues. Autoimmune diseases are mostly chronic in nature and there is no curative therapy., Dermatomyositis, Type 1 diabetes Hashimoto's disease, Sjogren's syndrome, Psoriasis are some of the examples of Autoimmune diseases. Systemic autoimmune diseases treatment and Localized autoimmune disease treatment are two types of autoimmune disease treatment.
Various types of treatments for these diseases include Physical therapy, blood transfusion, Recombinant technology, Chemo therapy, Topical therapy, TNF-a antagonists and Helminthic therapy. Women, generally, have higher incidences of these diseases compared to men.
Dominance of North America and Europe in autoimmune disease market can be attributed to factors like prevalence of autoimmune diseases, increasing investments in R&D and higher disposable income in these regions. Factors such as improving health infrastructure, increasing awareness among people about heath care and increasing aging populations are going to fuel the rapid growth of autoimmune disease treatment market in Asia-Pacific region in the next five years.
Availability of various biosimilar drugs, Government initiatives and support to restrict autoimmune diseases are also major factors contributing for the growth of this market. Lack of standardized treatment for these diseases, Poorly trained physicians, low medical insurance coverage and low levels of awareness among public about these diseases are some of the challenges for this industry.
This industry comprises price based intense competition among various players. Some of the major players operating in autoimmune disease treatment market include Abott Laboratories, Roche, Johnson&Johnson, Beckman Coulter Inc., Pfizer, Lupin Limited and GlaxoSmithKline plc.
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Market Overview
- Definition
- Value Chain Analysis
- Porter's 5 Forces
- Regulations
4. Market Dynamics
- Introduction
- Drivers
- Constraints
- Opportunities
5. Global Autoimmune Disease Treatment Market Segmentation, Forecasts and Trends - By Revenue
6. By Disease type
- Localized
- Systemic
7. By Diagonostics
- IFA
- ELISA
- Dot blot
- Line blot
- Aggultination
- Double immune diffusion
- Western Blotting
- Multiplex immunoassay
- Others
8. By Products
- Drugs
- Therapeutic and monitoring equipment
- Diagonostic equipments
9. By Region
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Switzerland
- Others
- Asia-Pacific
- China
- India
- Japan
- Australia
- Others
- Latin America
- Mexico
- Brazil
- Argentina
- Others
- MEA
- UAE
- Saudi Arabia
- South Africa
- Others
10. Vendor Market Share Analysis
11. Company Profiles
- Abbott Laboratories
- Active Biotech
- Eli Lilly
- Bristol-Myers Squibb
- AstraZeneca plc
- Pfizer
- Biogen Idec
- Lupin Limited
- GlaxoSmithKline
- Amgen
- 4SC AG
- F. Hoffmann-La Roche Ltd.
- AutoImmune Inc
- Johnson & Johnson
- Bayer
- Others
12. Industry Structure
- Industry M&As, Consolidations
- Investment Opportunities
13. Global Autoimmune Disease Treatment market - Road Ahead
- Tables
- Disclaimer
For more information about this report visit https://www.researchandmarkets.com/research/389pn9/global_autoimmune
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
